Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2002
03/14/2002CA2421558A1 Method of monitoring the effect of cathepsin s inhibitors
03/14/2002CA2421523A1 System and method for tracking and controlling infections
03/14/2002CA2421469A1 Drug discover employing calorimetric target triage
03/14/2002CA2421436A1 Culture medium and method for identifying gram-negative microorganisms
03/14/2002CA2421431A1 An electronic database of enzyme substrate and enzyme inhibitor structures
03/14/2002CA2421391A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
03/14/2002CA2421380A1 Biopanning and rapid analysis of selective interactive ligands (brasil)
03/14/2002CA2421324A1 Mutant non-human mammal for expressing the alpha6 acetylcholine nicotinic receptor subunit and use for screening substances capable of interacting with said receptor
03/14/2002CA2421293A1 Process for estimating random error in chemical and biological assays
03/14/2002CA2421271A1 Human and mouse targeting peptides identified by phage display
03/14/2002CA2421265A1 Molecules for diagnostics and therapeutics
03/14/2002CA2421248A1 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds
03/14/2002CA2421218A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002CA2421204A1 Method and system for detecting nucleic acids
03/14/2002CA2421203A1 Method and system for identifying commercially distributed organisms
03/14/2002CA2421200A1 Adenoviral targeting and manipulation of immune system response using targeting peptides
03/14/2002CA2421197A1 Generation of combinatorial libraries and assessment thereof by deconvolution
03/14/2002CA2421195A1 Compositions and methods for targeting peptides in humans in vivo
03/14/2002CA2421191A1 Methods and compositions for in vitro targeting
03/14/2002CA2421187A1 Family member of inhibitor of apoptosis proteins
03/14/2002CA2421155A1 Osteoclast-associated receptor
03/14/2002CA2421075A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002CA2421041A1 Caveolin peptides and their use as therapeutics
03/14/2002CA2421027A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002CA2420588A1 Polyhydroxyalkanoate levels as an indicator of bioreactor health
03/14/2002CA2419983A1 Screening methods to identify compounds that modulate a response of a cell to ultraviolet radiation exposure
03/14/2002CA2419975A1 Enzymes having high temperature polymerase activity and methods of use thereof
03/14/2002CA2419456A1 Methods and compositions for producing a neurosalutary effect in a subject
03/14/2002CA2416858A1 High growth methanotrophic bacterial strain methylomonas 16a
03/14/2002CA2416336A1 Multivalent neuraminidase inhibitor conjugates
03/13/2002EP1187269A2 IC card connector with grounding terminal member and its grounding terminal member
03/13/2002EP1186673A2 Calibration of molecular array data
03/13/2002EP1186672A2 Polymorphisms in the human organic anion transporter C (OATP-C) gene
03/13/2002EP1186671A2 Method for hybridization of arrays on siliceous surfaces
03/13/2002EP1186670A2 Apparatus for measuring the genetic sequence of biopolymers
03/13/2002EP1186669A1 Method for specific detection of DNS sequences using parallel amplification
03/13/2002EP1186661A1 Identification of the major capacitative calcium channel in antigen presenting cells and uses thereof
03/13/2002EP1186660A2 Method for obtaining DNA, RNA, peptides, polypeptides or proteins by means of a DNA-recombination technique
03/13/2002EP1186659A1 Nucleotide detector, process for producing the same and process for forming fine particle membrane
03/13/2002EP1186656A1 Method for preparing or removal of circoviruses from biological material
03/13/2002EP1186614A2 Crystal structure of the 30S ribosome bound to antibiotics
03/13/2002EP1185948A1 Method for screening and producing compound libraries
03/13/2002EP1185873A1 Reporter molecules and methods for assaying high specificity protease activity
03/13/2002EP1185868A1 Analytic sensor apparatus and method
03/13/2002EP1185864A1 Protein localization assays for toxicity and antidotes thereto
03/13/2002EP1185850A1 Apparatus and methods for sample delivery
03/13/2002EP1185713A2 Search method for resistance to anti-proteases of a strain of the HIV 2 virus from a biological sample taken from a patient
03/13/2002EP1185712A1 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
03/13/2002EP1185711A1 Compositions and methods for labeling of nucleic acid molecules
03/13/2002EP1185710A2 Viral detection method using viral encoded enzymes and chemiluminescent substrates
03/13/2002EP1185709A1 Device and method for storing information
03/13/2002EP1185708A1 Means for identifying a novel class of genes resistant to the rice yellow mottle virus and the locus of a major gene of resistance to the virus, and their applications
03/13/2002EP1185707A1 Means for identifying the locus of a major resistance gene with respect to the virus of the rice yellow mottle virus and uses thereof
03/13/2002EP1185706A1 METHOD FOR PRODUCING COMPLEX MIXTURES OF cDNA AND USES OF SAID MIXTURES FOR GENE EXPRESSION ANALYSIS
03/13/2002EP1185705A2 Reverse transcriptase assay kit, use thereof and method for analysis of rt activity in biological samples
03/13/2002EP1185704A2 Detection system for analyzing molecular interactions, production and utilization thereof
03/13/2002EP1185703A2 CoRT-PCR ASSAY FOR THE DISCRIMINATION OF ENDOGENOUS REVERSE TRANSCRIPTASE ACTIVITY IN EUKARYOTIC CELL LINES FROM INFECTIOUS RETROVIRUS CONTAMINATION
03/13/2002EP1185702A2 Nucleic acid probes and methods for detecting clinically important fungal pathogens
03/13/2002EP1185701A1 Gene specific arrays and the use thereof
03/13/2002EP1185700A1 49 human secreted proteins
03/13/2002EP1185699A1 Microarray-based subtractive hybridization
03/13/2002EP1185697A2 Assay based on the analysis of dna melting curves
03/13/2002EP1185696A1 Antisense oligonucleotide modulation of human protein kinase c-delta expression
03/13/2002EP1185695A1 Process for high throughput dna methylation analysis
03/13/2002EP1185694A1 49 human secreted proteins
03/13/2002EP1185693A2 Methods for improving sensitivity and specificity of screening assays
03/13/2002EP1185692A1 Monolayer and electrode for detecting a label-bearing target and method of use thereof
03/13/2002EP1185691A1 Neisseria genomic sequences and methods of their use
03/13/2002EP1185689A1 Reporter molecules and methods for assaying the lipidation status of a cell
03/13/2002EP1185688A2 Method and apparatus for enzyme detection
03/13/2002EP1185687A1 Methods for increasing t cell proliferation
03/13/2002EP1185686A1 Culture medium for detection of dekkera and brettanomyces
03/13/2002EP1185685A1 Culture medium for the detection of zygosaccharomyces
03/13/2002EP1185684A1 Electrochemical biosensor and chip for such a biosensor
03/13/2002EP1185678A2 R1 protein from wheat and the use thereof for the production of modified strach
03/13/2002EP1185673A2 Novel calpains and their use
03/13/2002EP1185672A2 Recombinant hosts suitable for simultaneous saccharification and fermentation
03/13/2002EP1185652A2 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto
03/13/2002EP1185650A1 Head trauma induced cytoplasmatic calcium binding protein
03/13/2002EP1185649A2 The myostatin gene promoter and inhibition of activation thereof
03/13/2002EP1185646A1 Recombinant nematode nicotinic receptor and uses
03/13/2002EP1185645A1 Adipocyte complement related protein homolog zacrp7
03/13/2002EP1185644A1 Assays for caspase activity using green fluorescent proteins
03/13/2002EP1185643A1 Adipocyte complement related protein homolog zacrp5
03/13/2002EP1185642A2 Compositions and methods for the treatment of tumor
03/13/2002EP1185641A1 Cytokine receptor mouse zcytor10
03/13/2002EP1185640A1 Lipocalin family protein
03/13/2002EP1185639A1 Prostate-specific gene, pcgem1, and methods of using pcgem1 to detect, treat, and prevent prostate cancer
03/13/2002EP1185626A2 A method for the transfer of antigens to dendritic cells
03/13/2002EP1185616A1 Method for rapidly detecting and enumerating microorganisms in mammalian cell preparations using atp bioluminescence
03/13/2002EP1185614A1 A model biofilm for efficacy assessment of antimicrobials
03/13/2002EP1185557A1 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
03/13/2002EP1185554A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
03/13/2002EP1185549A2 Dna encoding a human subunit of the 5-ht3 serotonin receptor
03/13/2002EP1185547A2 Gene expression modulated in gastrointestinal inflammation
03/13/2002EP1185546A1 High specificity primers, amplification methods and kits
03/13/2002EP1185545A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics
03/13/2002EP1185543A1 50 human secreted proteins
03/13/2002EP1185295A2 Adenosine diphosphatase and activators thereof and their medical uses
03/13/2002EP1185285A1 49 human secreted proteins